No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Chromosomes, Human, Pair 13
-
Clinical Trials, Phase III as Topic
-
Dexamethasone / administration & dosage
-
Disease Progression
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Drug Administration Schedule
-
Follow-Up Studies
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / mortality
-
Multiple Myeloma / pathology
-
Randomized Controlled Trials as Topic
-
Stem Cell Transplantation*
-
Survival Analysis
-
Thalidomide / therapeutic use*
-
Time Factors
-
Transplantation, Autologous
-
Treatment Outcome
-
Vincristine / administration & dosage
Substances
-
Immunosuppressive Agents
-
Thalidomide
-
Vincristine
-
Dexamethasone
-
Doxorubicin